Anti-TNF-α in the treatment of non-infectious uveitis

被引：3

作者：

Hoogewoud, Florence ^{[1
,2
]}

Kowalczuk, Laura ^{[2
,3
]}

Bousquet, Elodie ^{[1
,3
]}

Brezin, Antoine ^{[1
,3
]}

Touchard, Elodie ^{[4
]}

Buggage, Ronald ^{[4
]}

Bordet, Thierry ^{[4
]}

Behar-Cohen, Francine ^{[1
,3
]}

机构：

[1] Univ Paris, Ophtalmopole Hop Cochin, Assistance Publ Fopitaux Paris, 27 Rue Faubourg St Jacques, F-75014 Paris, France

[2] Univ Lausanne, Dept Ophtalmol, Hop Ophtalmol Jules Gonin, Lausanne, Switzerland

[3] Univ Paris, Inserm UMR 1138, Physiopathol Malad Oculaires Innovat Therapeut, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France

[4] Eyevensys SAS, Paris, France

来源：

M S-MEDECINE SCIENCES | 2020年 / 36卷 / 10期

关键词：

TUMOR-NECROSIS-FACTOR; LONG-TERM EFFICACY; ANTERIOR UVEITIS; ELECTROTRANSFER; ADALIMUMAB; INFLIXIMAB; DELIVERY; PRINCIPLES; THERAPY; FLARES;

D O I：

10.1051/medsci/2020160

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Non-infectious uveitis is a heterogenous group of potentially blinding ocular autoimmune diseases that may represent a manifestation of a systemic condition or may affect the eyes only. A systemically administered anti-TNF has recently been approved for the treatment of non-infectious uveitis, broadening the therapeutic arsenal available to control intraocular inflammation and reduce uveitis complications that can lead to vision loss. When uveitis affects only the eyes, a local anti-TNF-alpha administration strategy could optimize the ocular therapeutic effect and reduce undesirable systemic side-effects. A new ocular method of non-viral gene therapy, currently in development, may broaden the indications for ocular anti-TNF-alpha agents, not only for uveitis but also for other diseases in which TNF-alpha-mediated neuro-inflammation has been demonstrated.

引用

页码：893 / 899

页数：7

共 50 条

[31] Systemic Corticosteroids in Non-infectious Uveitis
Ness, Thomas
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (05) : 592 - 596
[32] Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product
Touchard, Elodie
Benard, Romain
Bigot, Karine
Laffitte, Jean-Denis
Buggage, Ronald
Bordet, Thierry
Behar-Cohen, Francine
JOURNAL OF CONTROLLED RELEASE, 2018, 285 : 244 - 251
[33] Non-infectious pediatric uveitis: An update on immunomodulatory management
Sharma S.M.
Dick A.D.
Ramanan A.V.
Pediatric Drugs, 2009, 11 (4) : 229 - 241
[34] Anti-TNF-α Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment
Kakkassery, Vinodh
Mergler, Stefan
Pleyer, Uwe
CURRENT EYE RESEARCH, 2010, 35 (08) : 751 - 756
[35] Anti-TNFα agents for refractory cystoid macular edema associated with non-infectious uveitis: A case report
Zghal, I.
Sayadi, J.
Fekih, O.
Romdhane, O.
Zgolli, H.
Bouguila, H.
Malek, I.
Nacef, L.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (03): : E88 - E90
[36] Non-Infectious Chronic Uveitis in Childhood: Assessment and Treatment in the Biological Era
Roberta Ponti
Maria Vincenza Mastrolia
Gabriele Simonini
Current Treatment Options in Rheumatology, 2020, 6 : 228 - 244
[37] Involvement of B cells in non-infectious uveitis
Smith, Justine R.
Stempel, Andrew J.
Bharadwaj, Arpita
Appukuttan, Binoy
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2016, 5
[38] Tocilizumab in severe and refractory non-infectious uveitis
Papo, M.
Bielefeld, P.
Vallet, H.
Seve, P.
Wechsler, B.
Cacoub, P.
Le Hoang, P.
Papo, T.
Bodaghi, B.
Saadoun, D.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S75 - S79
[39] Corticosteroid implants for chronic non-infectious uveitis
Brady, Christopher J.
Villanti, Andrea C.
Law, Hua Andrew
Rahimy, Ehsan
Reddy, Rahul
Sieving, Pamela C.
Garg, Sunir J.
Tang, Johnny
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
[40] The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis
Melissa A. Lerman
C. Egla Rabinovich
Pediatric Drugs, 2015, 17 : 283 - 301

← 1 2 3 4 5 →